COVADIS Summit XIV - Stuttgart, 31 August - 2 September 2026th

2026 COVADIS Summit (Stuttgart, 31 August-2 September 2026)
CESTChair / Speaker
Monday August 31
pmTransfer from Munich
1800Steering Committee Meeting
1930Summit Dinner
Tuesday September 1
900WelcomeProgram OverviewNoel Bairey Merz (US)John Beltrame (AU)
1. National Network UpdatesVijay Kunadian (UK)Udo Sechtem (DE)
0910Australia & New Zealand (CSANZ CVD Working Group)John Beltrame (AU)
0915Belgium (BELmicro Registry)Vincent Segers (BE)
0920Canada (Canadian INOCA Physiology Working Group)John Blair (CA)
0925Czech Republic (CoroPhys-CZECH)Petr Kala (CZ)
0930Italy (Italian Registry)Luigi Di Serafino (IT)
0935Japan (JCMD)Hiroaki Shimokawa (JP)
0940Republic of KoreaSang-Ho Jo (KR)
0945Netherlands (NL-CFT)Peter Damman (NL)
0950Singapore (Singapore CMD Network)Hui Wen Sim (SG)
0955Spain (Spanish Registry)Eva Rumiz (ES)
1000United Kingdom (UK Microvascular Dysfunction Working Group)Haseeb Rahman (UK)
1005United States (Microvascular Network)Nathaniel Smilowitz (US)
1010Uruguay (Uruguay ANOCA/INOCA Working Group)Rafael Mila (UY)
1015Welcome Leap Program – VISIBLE: Women’s Heart Disease RevealedBrigit Vogel (US)
1025Discussion: Global Collaboration – It’s a Small World After All!Open Discussion
1115Coffee Break
1145COVADIS Clinical StudiesJohanna McChord (DE)Jon Spiro (AU)
1145FUNCAGE (Functional Coronary Angiography Global Experience)Christopher Zeitz (AU)Hiroaki Shimokawa (JP)
1200Inter-CMD (International CMD Registry)Hiroaki Shimokawa (JP)
1215Coronary Microvascular Dysfunction Non-Invasive ImagingPuja Mehta (US)Colin Berry (UK)
1215State of the Art in Non-invasive CMD ImagingJanet Wei (US)
1235Endotypes and Prognosis – Role of Non-invasive ImagingEva Prescott (DK)
1255CMR Perfusion MethodsAmedeo Chiribiri (UK)
1315Lunch
Tuesday September 1 (continued)
1415Young Investigator PresentationsOdayme Quesada (US)Jennifer Tremmel (US)
1415Myocardial bridging is associated with focal coronary artery spasm in ANOCAFleur Adriaansen (NL)
1430Long-term follow-up of patients with coronary vasomotor dysfunction undergoing coronary function testing in the NetherlandsFleur Adriaansen (NL)
1445Differences in cardiovascular risk profiles between patients with obstructive coronary artery disease and ANOCA patients with coronary vasomotor dysfunction: insights from two multicentre registriesFleur Adriaansen (NL)
1500Coronary microvascular spasm preceding epicardial spasm at intracoronary acetylcholine testing – An ACOVA registry studyA. Fischer (DE)
1515Sex differences in patients with ANOCA and confirmed coronary vasomotor dysfunctionA. Gauck (DE)
1530Spatial heterogeneity of coronary vasomotor dysfunction in ANOCA demonstrated by systematic multivessel assessment in the Nationwide J-CMD RegistryKaisei Hosokawa (JP)
1545Long-term angina-related healthcare utilization in women with ANOCA and impaired coronary flow velocity reserveLaura Rytoft (DA)
1600Robert Bosch Institute Tour and Conference Dinner
Wednesday September 2
0900Remembering Prof Amir LermanNoel Bairey Merz (US)
09021. Functional Coronary Angiography Live Demonstration (Case-1)Peter Ong (DE) – Cath LabJavier Escaned (ES) – LabJennifer Tremmel (US) - Conf
0902• Case-1 (How to Perform Functional Coronary Angiography)Christopher Zeitz (AU)
1015Coffee Break
1045ANOCA Nomenclature ReviewNoel Bairey Merz (US)Tim van de Hoef (NL)
1045• Vasospastic AnginaJohn Beltrame (AU)
1050• Microvascular AnginaPeter Ong (DE)
1055• Functional Coronary Angiography EndotypesTommaso Gori (DE)
1100• Discussion
11303. Functional Coronary Angiography Live Demonstration (Case-2)Andreas Seitz (DE) – LabPeter Damman (NL) – LabChris Zeitz (AU) - Conf
1130• Case-2 (Bolus vs Continuous Thermodilution Techniques)Tim van de Hoef (NL)Javier Escaned (ES)
1230CloseJohn Beltrame (AU) and Noel Bairey Merz (US)